Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study

INTRODUCTION: The metabolic syndrome (MetS) may contribute to the excess cardiovascular burden observed in rheumatoid arthritis (RA). The prevalence and associations of the MetS in RA remain uncertain: systemic inflammation and anti-rheumatic therapy may contribute. Methotrexate (MTX) use has recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Toms, Tracey E, Panoulas, Vasileios F, John, Holly, Douglas, Karen MJ, Kitas, George D
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745792/
https://www.ncbi.nlm.nih.gov/pubmed/19607680
http://dx.doi.org/10.1186/ar2765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745792/
https://www.ncbi.nlm.nih.gov/pubmed/19607680
http://dx.doi.org/10.1186/ar2765

Ejemplares similares